Nalcrom (sodium cromoglicate)
“Sodium cromoglycate is considered to exert a stabilizing effect upon mast cells capable of releasing mediators. In gastrointestinal disease the release of mediators causes a local inflammation which can either result in gastrointestinal symptoms or may allow absorption of
antigenic material leading to systemic allergic reactions. Sodium cromoglycate has no antihistaminic or anti-inflammatory activity.”
Sodium Cromoglycate capsules as of 10 September 2021:
We understand from Sanofi that the Nalcrom branded capsules will be back in stock in November 2021.
There are two new licensed sodium cromoglycate products that we hope will meet all or at least much of the demand over the next several months.
Rosemont Pharmaceuticals is distributing a licensed liquid sodium cromoglycate (100mg/ampoule) dissolved in water. This is produced by Brown + Burk.
The Department of Health and Social Care have informed us that during the week ending 17 September Somex Pharmaceuticals will begin distributing sodium cromoglycate capsules (1oo mg/capsule) produced by Iilco. These will be distributed via all three major wholesalers (AAH, Phoenix and Alliance).
Nalcrom capsules update as of 17 May 2021:
Nalcrom is expected back with UK distributors in the week commencing 24 May, 2021. It will be distributed only by Phoenix and AAH, who supply to pharmacies. As these may not the usual distributors your pharmacy uses, you may need to direct your pharmacist to try these distributors.
Intal inhaler update as of 17 May 2021:
Intal inhalers should be available via Phoenix and AAH, distributors who supply to pharmacies. They became available as of the week commencing 10 May, 2021. As these may not the usual distributors your pharmacy uses, you may need to direct your pharmacist to try these distributors.